Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Nervous System Sensitization as a Predictor of Outcome in the Treatment of Peripheral Musculoskeletal Conditions: A Systematic Review.

O'Leary H, Smart KM, Moloney NA, Doody CM.

Pain Pract. 2016 Aug 19. doi: 10.1111/papr.12484. [Epub ahead of print] Review.

PMID:
27538534
2.

Enhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizure.

O'Leary H, Bernard PB, Castano AM, Benke TA.

Neurobiol Dis. 2016 Mar;87:134-44. doi: 10.1016/j.nbd.2015.12.005.

PMID:
26706598
3.

Detecting autonomic response to pain in Rett syndrome.

O'Leary HM, Marschik PB, Khwaja OS, Ho E, Barnes KV, Clarkson TW, Bruck NM, Kaufmann WE.

Dev Neurorehabil. 2015 Oct 12:1-7. [Epub ahead of print]

PMID:
26457613
4.

Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.

Barnes KV, Coughlin FR, O'Leary HM, Bruck N, Bazin GA, Beinecke EB, Walco AC, Cantwell NG, Kaufmann WE.

J Neurodev Disord. 2015;7(1):30. doi: 10.1186/s11689-015-9127-4.

5.

Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.

Mantel CR, O'Leary HA, Chitteti BR, Huang X, Cooper S, Hangoc G, Brustovetsky N, Srour EF, Lee MR, Messina-Graham S, Haas DM, Falah N, Kapur R, Pelus LM, Bardeesy N, Fitamant J, Ivan M, Kim KS, Broxmeyer HE.

Cell. 2015 Jun 18;161(7):1553-65. doi: 10.1016/j.cell.2015.04.054.

6.

Pain sensitisation and the risk of poor outcome following physiotherapy for patients with moderate to severe knee osteoarthritis: protocol for a prospective cohort study.

O'Leary H, Smart KM, Moloney NA, Blake C, Doody CM.

BMJ Open. 2015 Jun 9;5(6):e007430. doi: 10.1136/bmjopen-2014-007430.

7.
8.

Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol.

Abkur TM, Saeed M, Ahmed SZ, McArthur R, Leahy M, O'Leary H, O'Keeffe D.

Clin Case Rep. 2015 Apr;3(4):255-9. doi: 10.1002/ccr3.195.

9.

Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis.

Tarquinio DC, Hou W, Neul JL, Lane JB, Barnes KV, O'Leary HM, Bruck NM, Kaufmann WE, Motil KJ, Glaze DG, Skinner SA, Annese F, Baggett L, Barrish JO, Geerts SP, Percy AK.

Pediatr Neurol. 2015 Jun;52(6):585-91.e2. doi: 10.1016/j.pediatrneurol.2015.02.007.

10.

Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength.

Barcomb K, Buard I, Coultrap SJ, Kulbe JR, O'Leary H, Benke TA, Bayer KU.

FASEB J. 2014 Aug;28(8):3810-9. doi: 10.1096/fj.14-250407.

11.

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.

Khwaja OS, Ho E, Barnes KV, O'Leary HM, Pereira LM, Finkelstein Y, Nelson CA 3rd, Vogel-Farley V, DeGregorio G, Holm IA, Khatwa U, Kapur K, Alexander ME, Finnegan DM, Cantwell NG, Walco AC, Rappaport L, Gregas M, Fichorova RN, Shannon MW, Sur M, Kaufmann WE.

Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4596-601. doi: 10.1073/pnas.1311141111.

12.

Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection.

Coultrap SJ, Freund RK, O'Leary H, Sanderson JL, Roche KW, Dell'Acqua ML, Bayer KU.

Cell Rep. 2014 Feb 13;6(3):431-7. doi: 10.1016/j.celrep.2014.01.005.

13.

A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.

Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D.

Br J Haematol. 2013 Oct;163(1):118-22. doi: 10.1111/bjh.12486.

PMID:
23909468
14.

Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity.

Berwick ZC, Dick GM, O'Leary HA, Bender SB, Goodwill AG, Moberly SP, Owen MK, Miller SJ, Obukhov AG, Tune JD.

Basic Res Cardiol. 2013 Sep;108(5):370. doi: 10.1007/s00395-013-0370-0.

15.

Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures.

Bernard PB, Castano AM, O'Leary H, Simpson K, Browning MD, Benke TA.

Neurobiol Dis. 2013 Nov;59:1-17. doi: 10.1016/j.nbd.2013.06.013.

16.

Concise review: role of DEK in stem/progenitor cell biology.

Broxmeyer HE, Mor-Vaknin N, Kappes F, Legendre M, Saha AK, Ou X, O'Leary H, Capitano M, Cooper S, Markovitz DM.

Stem Cells. 2013 Aug;31(8):1447-53. doi: 10.1002/stem.1443. Review.

17.

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.

Ou X, O'Leary HA, Broxmeyer HE.

Blood. 2013 Jul 11;122(2):161-9. doi: 10.1182/blood-2013-02-487470. Review.

18.

The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.

O'Leary H, Ou X, Broxmeyer HE.

Curr Opin Hematol. 2013 Jul;20(4):314-9. doi: 10.1097/MOH.0b013e32836125ac. Review.

19.

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis.

Broxmeyer HE, Hoggatt J, O'Leary HA, Mantel C, Chitteti BR, Cooper S, Messina-Graham S, Hangoc G, Farag S, Rohrabaugh SL, Ou X, Speth J, Pelus LM, Srour EF, Campbell TB.

Nat Med. 2012 Dec;18(12):1786-96. doi: 10.1038/nm.2991.

20.

Continuous quantitative monitoring of cerebral oxygen metabolism in neonates by ventilator-gated analysis of NIRS recordings.

Heldt T, Kashif FM, Sulemanji M, O'Leary HM, du Plessis AJ, Verghese GC.

Acta Neurochir Suppl. 2012;114:177-80. doi: 10.1007/978-3-7091-0956-4_34.

Items per page

Supplemental Content

Loading ...
Support Center